Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
7.63 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2001 Q3 | 2001 Q2 | 2001 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 56.206 | 37.944 | 34.755 | 55.43 | 80.568 | 80.702 | 98.285 | 66.398 | 144.618 | 168.405 | 148.494 | 77.61 | 43.636 | 44.097 | 32.058 | 13.302 | 10.163 | 21.134 | 66.398 | 144.618 | 168.405 |
| Cost of Revenue
| 31.051 | 22.071 | 15.948 | 6.923 | 18.096 | 22.375 | 30.218 | 24.655 | 63.911 | 85.432 | 66.578 | 22.302 | 17.11 | 23.7 | 13.842 | 1.769 | 0 | 0 | 2.66 | 2.444 | 8.095 |
| Gross Profit
| 25.155 | 15.873 | 18.807 | 48.507 | 62.472 | 58.327 | 68.067 | 41.743 | 80.707 | 82.973 | 81.916 | 55.308 | 26.526 | 20.397 | 18.216 | 11.533 | 10.163 | 21.134 | 63.738 | 142.174 | 160.31 |
| Gross Profit Ratio
| 0.448 | 0.418 | 0.541 | 0.875 | 0.775 | 0.723 | 0.693 | 0.629 | 0.558 | 0.493 | 0.552 | 0.713 | 0.608 | 0.463 | 0.568 | 0.867 | 1 | 1 | 0.96 | 0.983 | 0.952 |
| Reseach & Development Expenses
| 116.891 | 123.588 | 107.701 | 156.662 | 144.282 | 162.639 | 181.155 | 259.58 | 289.188 | 322.72 | 985.025 | 53.021 | 52.031 | 59.585 | 61.191 | 36.07 | 32.27 | 30.236 | 259.58 | 289.188 | 322.72 |
| General & Administrative Expenses
| 66.285 | 70.287 | 89.223 | 82.028 | 102.341 | 111.433 | 121.42 | 435.184 | 438.427 | 434.768 | 781.626 | 28.959 | 34.44 | 17.927 | 12.913 | 9.876 | 8.949 | 6.568 | 435.184 | 438.427 | 434.768 |
| Selling & Marketing Expenses
| -7.491 | -19.265 | -23.663 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 58.794 | 51.022 | 65.56 | 82.028 | 102.341 | 111.433 | 121.42 | 435.184 | 438.427 | 434.768 | 781.626 | 28.959 | 34.44 | 17.927 | 12.913 | 9.876 | 8.949 | 6.568 | 435.184 | 438.427 | 434.768 |
| Other Expenses
| -0.766 | 2.015 | 0.093 | 2.893 | 3.224 | 2.928 | 7.005 | -0.957 | -0.051 | 1.637 | -1.617 | -4.911 | 7.119 | -1.345 | 1.784 | 5.894 | 0 | 0 | 24.655 | 63.911 | 85.432 |
| Operating Expenses
| 175.685 | 174.61 | 173.261 | 238.69 | 246.623 | 274.072 | 302.575 | 694.764 | 727.615 | 757.488 | 1,766.651 | 81.98 | 86.471 | 77.512 | 74.104 | 45.946 | 38.718 | 45.946 | 719.419 | 791.526 | 842.92 |
| Operating Income
| -150.53 | -158.737 | -154.454 | -286.393 | -184.151 | -215.745 | -234.508 | -653.021 | -646.908 | -674.515 | -1,684.735 | -26.672 | -59.945 | -57.115 | -55.888 | -34.413 | -31.056 | -15.67 | -653.021 | -646.908 | -674.515 |
| Operating Income Ratio
| -2.678 | -4.183 | -4.444 | -5.167 | -2.286 | -2.673 | -2.386 | -9.835 | -4.473 | -4.005 | -11.345 | -0.344 | -1.374 | -1.295 | -1.743 | -2.587 | -3.056 | -0.741 | -9.835 | -4.473 | -4.005 |
| Total Other Income Expenses Net
| -66.461 | -7.143 | -57.438 | -127.75 | -3.446 | 10.858 | 45.584 | -16.062 | -23.707 | 81.738 | 79.112 | -75.412 | 5.528 | -17.347 | 13.07 | 5.567 | 2.332 | -7.929 | -16.062 | -23.707 | 81.738 |
| Income Before Tax
| -216.991 | -165.88 | -211.892 | -302.913 | -173.248 | -204.887 | -188.924 | -669.083 | -670.615 | -592.777 | -1,605.678 | -102.612 | -54.895 | -74.937 | -46.391 | -26.12 | -28.724 | -23.599 | -669.083 | -670.615 | -592.777 |
| Income Before Tax Ratio
| -3.861 | -4.372 | -6.097 | -5.465 | -2.15 | -2.539 | -1.922 | -10.077 | -4.637 | -3.52 | -10.813 | -1.322 | -1.258 | -1.699 | -1.447 | -1.964 | -2.826 | -1.117 | -10.077 | -4.637 | -3.52 |
| Income Tax Expense
| 0.19 | 0.031 | -0.198 | -0.022 | 0.067 | 0.082 | -14.77 | -0.028 | -0.045 | -0.184 | -0.683 | -0.207 | -0.431 | -0.159 | 0.008 | 0.006 | 0.006 | 1.869 | -0.028 | -0.045 | -0.184 |
| Net Income
| -217.181 | -165.911 | -211.694 | -302.891 | -173.315 | -204.969 | -176.544 | -670.131 | -668.825 | -590.505 | -1,600.656 | -101.881 | -53.941 | -73.569 | -46.924 | -26.055 | -28.658 | -24.972 | -669.055 | -670.57 | -592.593 |
| Net Income Ratio
| -3.864 | -4.373 | -6.091 | -5.464 | -2.151 | -2.54 | -1.796 | -10.093 | -4.625 | -3.506 | -10.779 | -1.313 | -1.236 | -1.668 | -1.464 | -1.959 | -2.82 | -1.182 | -10.076 | -4.637 | -3.519 |
| EPS
| -4.23 | -3.31 | 0 | -6.21 | -3.59 | -4.28 | -3.81 | -0.41 | -0.41 | -0.37 | -1.05 | -0.08 | -0.04 | -0.05 | -0.032 | -0.018 | -3.67 | -3.2 | -0 | -0 | -0 |
| EPS Diluted
| -4.23 | -3.31 | 0 | -6.21 | -3.59 | -4.28 | -3.8 | -0.41 | -0.41 | -0.37 | -1.1 | -0.08 | -0.04 | -0.05 | -0.032 | -0.018 | -3.67 | -3.2 | -0 | -0 | -0 |
| EBITDA
| -133.2 | -145.868 | -141.617 | -39.049 | -159.327 | -191.621 | -234.204 | -654.807 | -622.136 | -684.277 | -1,690.519 | -62.834 | -55.535 | -81.455 | -51.328 | -25.438 | -27.877 | -12.516 | -653.021 | -646.908 | -674.515 |
| EBITDA Ratio
| -2.37 | -3.844 | -4.075 | -0.704 | -1.978 | -2.374 | -2.383 | -9.862 | -4.302 | -4.063 | -11.384 | -0.81 | -1.273 | -1.847 | -1.601 | -1.912 | -2.743 | -0.592 | -9.835 | -4.473 | -4.005 |